Article info
Clinical trial
Use of PROM during follow-up of patients with ovarian cancer: the PROMova study protocol
- Correspondence to Dr Anette Stolberg Kargo, Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle 7100, Denmark; Anette.Stolberg.Kargo{at}rsyd.dk
Citation
Use of PROM during follow-up of patients with ovarian cancer: the PROMova study protocol
Publication history
- Accepted May 15, 2020
- First published June 24, 2020.
Article Versions
- View the most recent version of this article
- You are currently viewing a Previous version of this article (23 November 2020).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.